Anti-human CD70 monoclonal antibody, vorsetuzumab biosimilar (SGN-70, h1F6)

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1041-100ug

  • Size

    100 ug

  • Price

    $350

1
This monoclonal antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
target CD70
alias CD70, CD27L, CD27LG, TNFSF7
gene id Uniprote ID: P32970
host species Human
reactivity Human
iso type IgG1
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml, solubilize at RT for 30 minutes with occasional gentle tapping. It is recommended that 0.1% HSA be added as a carrier protein for long-term storage.
applications ELISA; Flow Cytometry
dilution ELISA 1:5000-10000; Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.
note Other commonly used names in publications refering to this antibody: SGN-70, h1F6

Images

ELISA plate coated with 2 ug/ml (100 ul/well) Human CD70, mFc-His tagged protein binds to anti-CD70 neutralizing antibody in a linear range of 3.91-139.9 ng/ml.

HEK293 cell line transfected with irrelevant protein (B) and human CD70 (A) were surface stained with anti-CD70 neutralizing antibody 1ug/ml (vorsetuzumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.


PRODUCT

  • SKU

    DMS1041-100ug

  • Size

    100 ug

  • Price

    $350

1